MENELDOR

Meneldor offers her customers the unique opportunity to invest alongside specialists, in exciting early stage up to and including phase 2 Biotech and Pharma companies. A sector often considered as very risky and highly complex. Meneldor thoroughly studies the science behind her potential portfolio companies. If the science is sound, then all other key aspects; IP, medical need, addressable markets, competition, risk, management, financial needs, valuation, etc., are assessed. Only if a target company meets our selection criteria, Meneldor will invest and invite her investors to participate... Meneldor manages the entire investment process from selection to exit, this entails a.o. a proper Due Diligence, regular re- porting, administration, syndicate building, etc. Meneldor has an unique open, flexible, evergreen investment model, where her investors, through a Dutch Cooperative, invest directly in a company. The bundling of financial power of several investors gives Meneldor the..

Also known as: Meneldor B.V.